{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:35:47Z","timestamp":1789648547716,"version":"4.0.0"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Therapeutic options for managing laryngotracheal stenosis (LTS) are limited. Endoscopy is a minimally invasive approach to treating LTS, but carries a high risk of stenosis recurrence. Mitomycin C (MMC) is often used as an adjunct therapy to delay the time to symptomatic recurrence of LTS. This review synthesizes the current literature on the topic of MMC as an adjunct treatment strategy for LTS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A focused literature search was carried out from PubMed on June 12, 2022 using the terms \u201cmitomycin c AND stenosis\u201d in all fields with no date limitations. Evidence-based recommendations relevant to the clinical application of MMC as an adjunct therapy for LTS were formulated. Three questions were addressed: 1) efficacy of MMC, 2) single versus multiple application(s) of MMC, and 3) safety of MMC. The evidence rating and recommendation strength were guided by the GRADE system.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Twenty-nine studies were reviewed. The efficacy of MMC as an adjunct therapy for LTS varied across studies. Randomized controlled trials have not shown an outcome difference with MMC use, although methodologic flaws including underpowering were noted. A meta-analysis of observational studies with a comparator arm found the unadjusted probability of remaining symptom-free for <jats:underline>&gt;<\/jats:underline>1 year is greater with versus without MMC application (73% vs. 35%). Single versus multiple application(s) of MMC resulted in similar restenosis rates at long-term follow-up. Complications related to MMC use are rarely reported using conventional doses (0.4\u00a0mg\/mL). Overall, the quality of evidence was low and the recommendation for intervention was weak.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>The role for MMC as an adjunct therapy in LTS is uncertain. While safe in its application, the efficacy of MMC in reducing stenosis recurrence remains a matter of debate. Large, prospective studies are needed to inform future recommendations.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/lbr.0000000000000933","type":"journal-article","created":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T04:01:22Z","timestamp":1685937682000},"page":"223-231","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Use of Mitomycin-C in Laryngotracheal Stenosis"],"prefix":"10.1097","volume":"30","author":[{"given":"Christopher","family":"Di Felice","sequence":"first","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Louis Stokes Cleveland VA Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Machuzak","sequence":"additional","affiliation":[{"name":"Department of Pulmonary, Allergy and Critical Care, Respiratory Institute, Cleveland Clinic, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ray W.","family":"Shepherd","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Virginia Commonwealth University Medical Center, Richmond, VA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,7]]},"reference":[{"key":"R2-20240809","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.thorsurg.2018.01.001","article-title":"Tracheal injuries complicating prolonged intubation and tracheostomy","volume":"28","author":"Cooper","year":"2018","journal-title":"Thorac Surg Clin"},{"key":"R3-20240809","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.21037\/jtd.2019.11.43","article-title":"Idiopathic subglottic stenosis: a review","volume":"12","author":"Aravena","year":"2020","journal-title":"J Thorac Dis"},{"key":"R4-20240809","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ejcts.2008.10.041","article-title":"Interventional endoscopy in the management of benign tracheal stenosis: definitive treatment at long-term follow-up","volume":"35","author":"Galluccio","year":"2009","journal-title":"Eur J Cardiothorac Surg"},{"key":"R5-20240809","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/lary.20056","article-title":"Mitomycin C and the endoscopic treatment of laryngotracheal stenosis: are two applications better than one?","volume":"119","author":"Smith","year":"2009","journal-title":"Laryngoscope"},{"key":"R6-20240809","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1288\/00005537-197903000-00016","article-title":"Therapy of iatrogenic subglottic stenosis: a steroid\/antibiotic regimen","volume":"89","author":"Croft","year":"1979","journal-title":"Laryngoscope"},{"key":"R7-20240809","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1001\/archotol.1972.00770090090012","article-title":"Intralesional steroids in laryngeal stenosis. A preliminary report","volume":"96","author":"Cobb","year":"1972","journal-title":"Arch Otolaryngol"},{"key":"R8-20240809","first-page":"63","article-title":"Intralesional steroids in conservative management of subglottic stenosis of the larynx","volume":"64","author":"Gnanapragasam","year":"1979","journal-title":"Int Surg"},{"key":"R9-20240809","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1055\/s-0039-1700582","article-title":"Mitomycin C in the endoscopic treatment of laryngotracheal stenosis: systematic review and proportional meta-analysis","volume":"24","author":"Queiroga","year":"2020","journal-title":"Int Arch Otorhinolaryngol"},{"key":"R10-20240809","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0163-7258(97)00088-0","article-title":"The mitomycin bioreductive antitumor agents: crosslinking and alkylation of DNA as the molecular basis of their activity","volume":"76","author":"Tomasz","year":"1997","journal-title":"Pharmacol Ther"},{"key":"R11-20240809","first-page":"610","article-title":"Studies on the pterygium. Part IV. A treatment of the pterygium by mitomycin-C instillation","volume":"67","author":"Kunitimo","year":"1963","journal-title":"Acta Soc Ophthalmol"},{"key":"R12-20240809","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0165-5876(98)00061-5","article-title":"Mitomycin-C in the treatment of tracheal cicatrix after tracheal reconstruction","volume":"44","author":"Ward","year":"1998","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"R13-20240809","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"R14-20240809","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/bmj.39490.551019.BE","article-title":"What is \u201cquality of evidence\u201d and why is it important to clinicians?","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"R15-20240809","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/bmj.39493.646875.AE","article-title":"Going from evidence to recommendations [published correction appears in BMJ. 2008 Jun 21;336(7658): doi:10.1136\/bmj.a402]","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"R16-20240809","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1177\/000348948209100412","article-title":"Predictive factors of success or failure in the endoscopic management of laryngeal and tracheal stenosis","volume":"91","author":"Simpson","year":"1982","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"R17-20240809","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/000348948509400608","article-title":"Carbon dioxide laser management of laryngeal stenosis","volume":"94","author":"Duncavage","year":"1985","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"R18-20240809","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1288\/00005537-198510000-00015","article-title":"Efficacy of bronchoscopic carbon dioxide laser surgery for benign strictures of the trachea","volume":"95","author":"Ossoff","year":"1985","journal-title":"Laryngoscope"},{"key":"R19-20240809","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/01.ede.0000135174.63482.43","article-title":"A structural approach to selection bias","volume":"15","author":"Hern\u00e1n","year":"2004","journal-title":"Epidemiology"},{"key":"R20-20240809","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1001\/jamaoto.2016.4131","article-title":"Endoscopic management of subglottic stenosis","volume":"143","author":"Feinstein","year":"2017","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"R21-20240809","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/lary.28025","article-title":"A randomized controlled trial of adjuvant mitomycin-c in endoscopic surgery for laryngotracheal stenosis","volume":"130","author":"Yung","year":"2020","journal-title":"Laryngoscope"},{"key":"R22-20240809","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1159\/000439174","article-title":"The efficacy of mitomycin c in the treatment of laryngotracheal stenosis: results and experiences with a difficult disease entity","volume":"77","author":"Reichert","year":"2015","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"key":"R23-20240809","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1097\/01.mlg.0000235934.27964.88","article-title":"The efficacy of mitomycin-C in the treatment of laryngotracheal stenosis","volume":"116","author":"Simpson","year":"2006","journal-title":"Laryngoscope"},{"key":"R24-20240809","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.otohns.2004.03.001","article-title":"Endoscopic treatment of laryngeal and tracheal stenosis-has mitomycin C improved the outcome?","volume":"131","author":"Perepelitsyn","year":"2004","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R25-20240809","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/archotol.127.10.1260","article-title":"Topical mitomycin application after laryngotracheal reconstruction: a randomized, double-blind, placebo-controlled trial","volume":"127","author":"Hartnick","year":"2001","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"R26-20240809","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/01.mlg.0000150694.08259.80","article-title":"Time and dose effects of mitomycin C on extracellular matrix fibroblasts and proteins","volume":"115","author":"Ferguson","year":"2005","journal-title":"Laryngoscope"},{"key":"R27-20240809","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/00005537-200401000-00027","article-title":"Clinical and histological healing of surgical wounds treated with mitomycin C","volume":"114","author":"Ribeiro Fde","year":"2004","journal-title":"Laryngoscope"},{"key":"R28-20240809","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.otohns.2006.02.024","article-title":"The effects of intradermal and topical mitomycin C on wound healing","volume":"135","author":"Porter","year":"2006","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R29-20240809","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1034\/j.1399-3003.1999.13d32.x","article-title":"Multidisciplinary approach to management of postintubation tracheal stenoses","volume":"13","author":"Brichet","year":"1999","journal-title":"Eur Respir J"},{"key":"R30-20240809","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/S0161-6420(92)31749-X","article-title":"Serious complications of topical mitomycin-C after pterygium surgery","volume":"99","author":"Rubinfeld","year":"1992","journal-title":"Ophthalmology"},{"key":"R31-20240809","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.otohns.2005.07.031","article-title":"Airway complications from topical mitomycin C","volume":"133","author":"Hueman","year":"2005","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R32-20240809","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0161-6420(90)32456-9","article-title":"Effects of 5-flurouracil and mitomycin C on cultured rabbit subconjunctival fibroblasts","volume":"97","author":"Yamamoto","year":"1990","journal-title":"Ophthalmology"},{"key":"R33-20240809","first-page":"692","article-title":"Apoptosis gene expression and death receptor signaling in mitomycin C-treated human tenon capsule fibroblasts","volume":"43","author":"Crowston","year":"2002","journal-title":"Investigative Ophthalmol Vis Sci"},{"key":"R34-20240809","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.otohns.2005.10.057","article-title":"Mitomycin-c application in airway stenosis surgery: analysis of safety and costs","volume":"134","author":"Ubell","year":"2006","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R35-20240809","doi-asserted-by":"crossref","first-page":"E206","DOI":"10.1002\/lary.28838","article-title":"In reply to mitomycin-C is ineffective in laryngotracheal surgery if used incorrectly","volume":"131","author":"Yung","year":"2021","journal-title":"Laryngoscope"},{"key":"R36-20240809","doi-asserted-by":"crossref","first-page":"E205","DOI":"10.1002\/lary.28834","article-title":"In reference to a randomized controlled trial of adjuvant mitomycin-C in endoscopic surgery for laryngotracheal stenosis","volume":"131","author":"Dikkers","year":"2021","journal-title":"Laryngoscope"},{"key":"R37-20240809","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/hed.23310","article-title":"Dose-dependent effect of mitomycin C on human vocal fold fibroblasts","volume":"36","author":"Li","year":"2014","journal-title":"Head Neck"},{"key":"R38-20240809","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000339613","article-title":"Wound repair and regeneration","volume":"49","author":"Reinke","year":"2012","journal-title":"Eur Surg Res"},{"key":"R39-20240809","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.amjoto.2018.07.016","article-title":"Office-based retrograde transtracheal application of mitomycin C","volume":"39","author":"Silva Merea","year":"2018","journal-title":"Am J Otolaryngol"}],"container-title":["Journal of Bronchology &amp; Interventional Pulmonology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/LBR.0000000000000933","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T15:29:12Z","timestamp":1723217352000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/LBR.0000000000000933"}},"subtitle":["A Focused Clinical Review"],"short-title":[],"issued":{"date-parts":[[2023,6,5]]},"references-count":38,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/lbr.0000000000000933","relation":{},"ISSN":["1948-8270"],"issn-type":[{"value":"1948-8270","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,5]]},"assertion":[{"value":"2023-02-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}